August 27, 2024 11:19 AM EDTUpdated 01:14 PM

Redalpine closes $200M fund; A base editing pact in China; Merck starts another Phase 3 for Imago drug

Plus, a Phase 3 fail from a small public company:

Redalpine’s $200M fund: The nearly two-decade-old VC firm

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER

Redalpine clos­es $200M fund; A base edit­ing pact in Chi­na; Mer­ck starts an­oth­er Phase 3 for Ima­go drug